Shattuck Labs (STTK) Stock Forecast, Price Target & Predictions
STTK Stock Forecast
Shattuck Labs stock forecast is as follows: an average price target of $12.00 (represents a 775.91% upside from STTK’s last price of $1.37) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
STTK Price Target
The average price target for Shattuck Labs (STTK) is $12.00 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $16.00 to $8.00. This represents a potential 775.91% upside from STTK's last price of $1.37.
STTK Analyst Ratings
According to 5 Wall Street analysts, Shattuck Labs's rating consensus is 'Hold'. The analyst rating breakdown for STTK stock is 0 'Strong Buy' (0.00%), 1 'Buy' (20.00%), 4 'Hold' (80.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Shattuck Labs Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 15, 2024 | Yigal Nochomovitz | Citigroup | $8.00 | $3.12 | 156.41% | 483.94% |
| Jun 20, 2024 | Joseph Pantginis | H.C. Wainwright | $16.00 | $4.59 | 248.58% | 1067.88% |
The latest Shattuck Labs stock forecast, released on Aug 15, 2024 by Yigal Nochomovitz from Citigroup, set a price target of $8.00, which represents a 156.41% increase from the stock price at the time of the forecast ($3.12), and a 483.94% increase from STTK last price ($1.37).
Shattuck Labs Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 2 |
| Avg Price Target | - | $8.00 | $12.00 |
| Last Closing Price | $1.37 | $1.37 | $1.37 |
| Upside/Downside | -100.00% | 483.94% | 775.91% |
In the current month, the average price target of Shattuck Labs stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Shattuck Labs's last price of $1.37. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 02, 2024 | Needham | Buy | Hold | Downgrade |
| Oct 01, 2024 | Citigroup | Buy | Neutral | Downgrade |
| Oct 01, 2024 | H.C. Wainwright | Buy | Neutral | Downgrade |
| Oct 01, 2024 | H.C. Wainwright | Buy | Negative | Downgrade |
| Oct 01, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Aug 28, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Aug 27, 2024 | Needham | Buy | Buy | Hold |
| Aug 15, 2024 | Citigroup | Buy | Buy | Hold |
| Aug 02, 2024 | H.C. Wainwright | Underperform | Underperform | Hold |
| Aug 02, 2024 | Needham | Buy | Buy | Hold |
Shattuck Labs's last stock rating was published by Needham on Oct 02, 2024. The company Downgrade its STTK rating from "Buy" to "Hold".
Shattuck Labs Financial Forecast
Shattuck Labs Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $714.00K | $686.00K | $200.00K | $57.00K | $390.00K | - | $30.08M | $1.90M | $-4.23M | $2.27M | $1.34M | $2.44M |
| Avg Forecast | $2.27M | $2.14M | $2.02M | $1.91M | $125.00K | $652.25K | $498.75K | $304.67K | $336.67K | $217.50K | $180.00K | $170.00K | $45.00K | $575.00K | $1.98M | $1.98M | $1.98M | $1.98M | $2.80M | $2.80M |
| High Forecast | $2.27M | $2.14M | $2.02M | $1.91M | $125.00K | $652.25K | $498.87K | $304.83K | $336.67K | $217.50K | $180.00K | $170.00K | $45.00K | $575.00K | $1.98M | $1.98M | $1.98M | $1.98M | $2.80M | $2.80M |
| Low Forecast | $2.27M | $2.14M | $2.02M | $1.91M | $125.00K | $652.25K | $498.63K | $304.50K | $336.67K | $217.50K | $180.00K | $170.00K | $45.00K | $575.00K | $1.98M | $1.98M | $1.98M | $1.98M | $2.80M | $2.80M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | 2.12% | 3.15% | 1.11% | 0.34% | 8.67% | - | 15.23% | 0.96% | -2.14% | 1.15% | 0.48% | 0.87% |
Shattuck Labs's average Quarter revenue forecast for Mar 24 based on 1 analysts is $304.67K, with a low forecast of $304.50K, and a high forecast of $304.83K. STTK's average Quarter revenue forecast represents a -57.33% decrease compared to the company's last Quarter revenue of $714.00K (Dec 23).
Shattuck Labs EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | $-19.81M | $-28.60M | $-22.75M | $-20.65M | $-26.28M | $-23.69M | $9.25M | $-17.03M | $-23.27M | $-11.59M | $-11.84M | $-11.67M |
| Avg Forecast | $-2.27M | $-2.14M | $-2.02M | $-1.91M | $-125.00K | $-652.25K | $-498.75K | $-304.67K | $-336.67K | $-217.50K | $-180.00K | $-170.00K | $-45.00K | $-575.00K | $-1.98M | $-1.98M | $-1.98M | $-14.85M | $-2.80M | $-2.80M |
| High Forecast | $-2.27M | $-2.14M | $-2.02M | $-1.91M | $-125.00K | $-652.25K | $-498.63K | $-304.50K | $-336.67K | $-217.50K | $-180.00K | $-170.00K | $-45.00K | $-575.00K | $-1.98M | $-1.98M | $-1.98M | $-11.88M | $-2.80M | $-2.80M |
| Low Forecast | $-2.27M | $-2.14M | $-2.02M | $-1.91M | $-125.00K | $-652.25K | $-498.87K | $-304.83K | $-336.67K | $-217.50K | $-180.00K | $-170.00K | $-45.00K | $-575.00K | $-1.98M | $-1.98M | $-1.98M | $-17.82M | $-2.80M | $-2.80M |
| Surprise % | - | - | - | - | - | - | - | - | 58.84% | 131.49% | 126.37% | 121.45% | 583.91% | 41.21% | -4.68% | 8.62% | 11.78% | 0.78% | 4.23% | 4.17% |
1 analysts predict STTK's average Quarter EBITDA for Mar 22 to be $-575.00K, with a high of $-575.00K and a low of $-575.00K. This is -106.22% lower than Shattuck Labs's previous annual EBITDA (Dec 21) of $9.25M.
Shattuck Labs Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | $-18.62M | $-27.54M | $-21.35M | $-19.79M | $-24.55M | $-24.89M | - | $-17.41M | $-23.60M | $-11.81M | $-12.01M | $-11.83M |
| Avg Forecast | $-10.16M | $-9.65M | $-9.65M | $-12.19M | $-17.69M | $-21.17M | $-21.04M | $-22.75M | $-28.84M | $-26.37M | $-26.25M | $-31.97M | $-31.98M | $-25.56M | $-21.84M | $-22.60M | $-17.78M | $-15.14M | $-19.88M | $-17.53M |
| High Forecast | $-10.16M | $-9.65M | $-9.65M | $-12.19M | $-17.69M | $-18.07M | $-21.04M | $-22.75M | $-28.84M | $-26.37M | $-26.25M | $-31.97M | $-31.98M | $-25.56M | $-21.84M | $-22.60M | $-17.78M | $-12.12M | $-19.88M | $-17.53M |
| Low Forecast | $-10.16M | $-9.65M | $-9.65M | $-12.19M | $-17.69M | $-23.75M | $-21.04M | $-22.75M | $-28.84M | $-26.37M | $-26.25M | $-31.97M | $-31.98M | $-25.56M | $-21.84M | $-22.60M | $-17.78M | $-18.17M | $-19.88M | $-17.53M |
| Surprise % | - | - | - | - | - | - | - | - | 0.65% | 1.04% | 0.81% | 0.62% | 0.77% | 0.97% | - | 0.77% | 1.33% | 0.78% | 0.60% | 0.67% |
Shattuck Labs's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. STTK's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Shattuck Labs SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | $4.44M | $5.07M | $4.74M | $5.05M | $4.78M | $4.98M | - | $4.34M | $5.40M | $4.36M | $3.57M | $2.47M |
| Avg Forecast | $19.81M | $18.71M | $17.67M | $16.69M | $1.09M | $5.70M | $4.36M | $2.66M | $2.94M | $1.90M | $1.57M | $1.49M | $393.24K | $5.02M | $17.26M | $17.26M | $17.26M | $17.26M | $24.47M | $24.47M |
| High Forecast | $19.81M | $18.71M | $17.67M | $16.69M | $1.09M | $5.70M | $4.36M | $2.66M | $2.94M | $1.90M | $1.57M | $1.49M | $393.24K | $5.02M | $17.26M | $17.26M | $17.26M | $17.26M | $24.47M | $24.47M |
| Low Forecast | $19.81M | $18.71M | $17.67M | $16.69M | $1.09M | $5.70M | $4.36M | $2.66M | $2.94M | $1.90M | $1.57M | $1.49M | $393.24K | $5.02M | $17.26M | $17.26M | $17.26M | $17.26M | $24.47M | $24.47M |
| Surprise % | - | - | - | - | - | - | - | - | 1.51% | 2.67% | 3.01% | 3.40% | 12.15% | 0.99% | - | 0.25% | 0.31% | 0.25% | 0.15% | 0.10% |
Shattuck Labs's average Quarter SG&A projection for Mar 24 is $2.66M, based on 1 Wall Street analysts, with a range of $2.66M to $2.66M. The forecast indicates a -40.01% fall compared to STTK last annual SG&A of $4.44M (Dec 23).
Shattuck Labs EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | $-0.00 | $-0.65 | $-0.50 | $-0.47 | $-0.58 | $-0.59 | - | $-0.41 | $-0.56 | $-0.28 | $-0.31 | $-0.31 |
| Avg Forecast | $-0.20 | $-0.19 | $-0.19 | $-0.24 | $-0.35 | $-0.42 | $-0.41 | $-0.45 | $-0.57 | $-0.52 | $-0.52 | $-0.63 | $-0.63 | $-0.50 | $-0.43 | $-0.45 | $-0.35 | $-0.39 | $-0.39 | $-0.35 |
| High Forecast | $-0.20 | $-0.19 | $-0.19 | $-0.24 | $-0.35 | $-0.36 | $-0.41 | $-0.45 | $-0.57 | $-0.52 | $-0.52 | $-0.63 | $-0.63 | $-0.50 | $-0.43 | $-0.45 | $-0.35 | $-0.39 | $-0.39 | $-0.35 |
| Low Forecast | $-0.20 | $-0.19 | $-0.19 | $-0.24 | $-0.35 | $-0.47 | $-0.41 | $-0.45 | $-0.57 | $-0.52 | $-0.52 | $-0.63 | $-0.63 | $-0.50 | $-0.43 | $-0.45 | $-0.35 | $-0.39 | $-0.39 | $-0.35 |
| Surprise % | - | - | - | - | - | - | - | - | 0.00% | 1.25% | 0.97% | 0.75% | 0.92% | 1.17% | - | 0.92% | 1.60% | 0.71% | 0.79% | 0.90% |
According to undefined Wall Street analysts, Shattuck Labs's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to STTK previous annual EPS of $NaN (undefined).
Shattuck Labs Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals | $1.60 | $24.75 | 1446.88% | Buy |
| IPSC | Century Therapeutics | $1.57 | $20.00 | 1173.89% | Buy |
| STTK | Shattuck Labs | $1.38 | $12.00 | 769.57% | Hold |
| PRLD | Prelude Therapeutics | $1.92 | $6.25 | 225.52% | Sell |
| ELYM | Eliem Therapeutics | $5.11 | $13.00 | 154.40% | Buy |
| STOK | Stoke Therapeutics | $13.27 | $30.60 | 130.60% | Buy |
| FHTX | Foghorn Therapeutics | $7.74 | $16.33 | 110.98% | Buy |
| CCCC | C4 Therapeutics | $6.41 | $13.50 | 110.61% | Buy |
| NRIX | Nurix Therapeutics | $24.72 | $31.44 | 27.18% | Buy |
| KYMR | Kymera Therapeutics | $46.25 | $51.50 | 11.35% | Buy |
STTK Forecast FAQ
Is Shattuck Labs a good buy?
No, according to 5 Wall Street analysts, Shattuck Labs (STTK) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 20.00% of STTK's total ratings.
What is STTK's price target?
Shattuck Labs (STTK) average price target is $12 with a range of $8 to $16, implying a 775.91% from its last price of $1.37. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Shattuck Labs stock go up soon?
According to Wall Street analysts' prediction for STTK stock, the company can go up by 775.91% (from the last price of $1.37 to the average price target of $12), up by 1067.88% based on the highest stock price target, and up by 483.94% based on the lowest stock price target.
Can Shattuck Labs stock reach $2?
STTK's average twelve months analyst stock price target of $12 supports the claim that Shattuck Labs can reach $2 in the near future.
What are Shattuck Labs's analysts' financial forecasts?
Shattuck Labs's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $1.58M (high $1.58M, low $1.58M), average EBITDA is $-1.581M (high $-1.58M, low $-1.581M), average net income is $-82.649M (high $-79.551M, low $-85.23M), average SG&A $13.81M (high $13.82M, low $13.81M), and average EPS is $-1.627 (high $-1.566, low $-1.678). STTK's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $8.34M (high $8.34M, low $8.34M), average EBITDA is $-8.339M (high $-8.339M, low $-8.339M), average net income is $-41.649M (high $-41.649M, low $-41.649M), average SG&A $72.87M (high $72.87M, low $72.87M), and average EPS is $-0.82 (high $-0.82, low $-0.82).
Did the STTK's actual financial results beat the analysts' financial forecasts?
Based on Shattuck Labs's last annual report (Dec 2023), the company's revenue was $1.66M, beating the average analysts forecast of $904.17K by 83.26%. Apple's EBITDA was $-91.957M, beating the average prediction of $-904K by 10070.36%. The company's net income was $-87.298M, missing the average estimation of $-113M by -23.03%. Apple's SG&A was $19.3M, beating the average forecast of $7.9M by 144.32%. Lastly, the company's EPS was $-0.002, missing the average prediction of $-2.233 by -99.91%. In terms of the last quarterly report (Dec 2023), Shattuck Labs's revenue was $714K, beating the average analysts' forecast of $336.67K by 112.08%. The company's EBITDA was $-19.811M, beating the average prediction of $-337K by 5784.45%. Shattuck Labs's net income was $-18.624M, missing the average estimation of $-28.837M by -35.42%. The company's SG&A was $4.44M, beating the average forecast of $2.94M by 50.85%. Lastly, the company's EPS was $-0.0004, missing the average prediction of $-0.568 by -99.93%